MGMT and glioblastoma: It is worth mentioning a currently ongoing individualized screening trial of innovative glioblastoma therapy (INSIGhT) designed as a randomized, multi-arm phase II trial for patients with newly diagnosed glioblastoma and unmethylated MGMT promoter (NCT02977780) [117].